Biochemistry and pharmacology of 7α-substituted androstenediones as aromatase inhibitors

Journal of Steroid Biochemistry and Molecular Biology

Volumn 61, Issue 3-6, 1997, Pages 247-254

  Brueggemeier, Robert W ^a   O'Reilly, Jill M ^a   Lovely, Carl J ^a   Ward, Patrick J ^a   Quinn, Anne L ^a   Baker, David ^a   Darby, Michael V ^a   Gu, Xin Ju ^a   Gilbert, Nancy E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA (4 AMINOPHENYLTHIO) 1,4 ANDROSTADIENE 3,17 DIONE; ANDROSTENEDIONE DERIVATIVE; AROMATASE; AROMATASE INHIBITOR; UNCLASSIFIED DRUG; ANDROSTENEDIONE; DRUG DERIVATIVE; ENZYME INHIBITOR;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG SYNTHESIS; ENZYME INHIBITION; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; RAT; ANIMAL; BREAST TUMOR; CHEMISTRY; REVIEW;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

ANDROSTENEDIONE; ANIMALS; AROMATASE INHIBITORS; BREAST NEOPLASMS; ENZYME INHIBITORS; FEMALE; HUMANS; RATS;

EID: 0031106983     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00208-7     Document Type: Conference Paper

References (20)

1. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., Michael M.D., Bulun S.E. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15:1994;342-355.
2. Brueggemeier R.W. Biochemical and molecular aspects of aromatase. J. Enzyme Inhib. 4:1990;101-111.
3. Marsh D.A., Brodie H.J., Garrett W., Tsai-Morris C.-H., Brodie A.M.H. Aromatase inhibitors: synthesis and biological activity of androstenedione derivatives. J. Med. Chem. 28:1985;788-795.
4. O'Reilly J.M., Brueggemeier R.W. Development of steroidal and nonsteroidal aromatase inhibitors for the treatment of hormone dependent breast cancer. Curr. Med. Chem. 2:1995;781-792.
5. Brueggemeier R.W. Aromatase inhibitors - mechanism of steroidal inhibitors. Breast Cancer Res. Treat. 30:1994;31-42.
6. Bossche H.V., Moereels H., Koymans L.M.H. Aromatase inhibitors - mechanisms for non-steroidal inhibitors. Breast Cancer Res. Treat. 30:1994;43-55.
7. Bhatnagar A.S., Hausler A., Schieweck K. Inhibition of aromatase in vitro and in vivo by aromatase inhibitors. J. Enzyme Inhib. 4:1990;179-186.
8. Banting L., Smith H.J., James M., Jones G., Nazareth W., Nichols P.J., Hewlins M.J.E., Rowland M.G. Structure-activity relationships for non-steroidal inhibitors of aromatase. J. Enzyme Inhib. 2:1988;215-229.
9. Cole P.A., Robinson C.H. Mechanism and inhibition of cytochrome P450 aromatse. J. Med. Chem. 33:1990;2933-2942.
10. Brueggemeier R.W., Floyd E.E., Counsell R.E. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis. J. Med. Chem. 21:1978;1007-1011.
11. Darby M.V., Lovett J.A., Brueggemeier R.W., Groziak M.P., Counsell R.E. 7α-Substituted derivatives of androstenediones as inhibitors of estrogen biosynthesis. J. Med. Chem. 28:1985;803-807.
12. Brueggemeier R.W., Katlic N.E. Effects of the aromatase inhibitor 7α-(4′-amino) phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture. Cancer Res. 47:1987;4548-4551.
13. Brueggemeier R.W., Li P.-K., Snider C.E., Darby M.V., Katlic N.E. 7α-Substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase. Steroids. 50:1987;164-178.
14. 19 steroid. J. Biol. Chem. 262:1987;8685-8689.
15. O'Reilly J.M., Li N., Duax W.L., Brueggemeier R.W. Synthesis, structure elucidation, and biochemical evaluation of 7α- and 7β-arylaliphatic-substituted androst-4-ene-3,17-dione as inhibitors of aromatase. J. Med. Chem. 38:1995;2842-2850.
16. Lovely C.J., Brueggemeier R.W. Synthesis of 7α-substituted androstenediones by a 1,4-conjugate addition approach. Bioorg. Med. Chem. Lett. 5:1995;2513-2516.
17. Cleland W.W. The statistical analysis of enzyme kinetic data. Methods Enzymol. 63:1979;103-138.
18. Brueggemeier R.W., Katlic N.E. Effects of an enzyme-activated irreversible aromatase inhibitor on human carcinoma cells in culture. Cancer Res. 50:1990;3652-3656.
19. Brueggemeier R.W., Katlic N.E., Kenreigh C.A., Li P.-K. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture. J. Steroid Biochem. Molec. Biol. 41:1992;85-90.
20. O'Reilly J.M., Brueggemeier R.W. 7α-Arylaliphatic androst-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase. J. Steroid Biochem. Molec. Biol. 59:1996;93-102.